EGF and glioblastoma: Thus, proliferation of U87MG was assessed in response to treatment with EGF (10 ng/mL), which plays an essential role in glioblastoma metastasis, and VEGF (10 ng/mL), which acts as a major angiogenic factor (Fig. 1a).